ArticleHeliyon2024
SARS-CoV-2 infection after COVID-19 vaccinations among vaccinated individuals, prevention rate of COVID-19 vaccination: A systematic review and meta-analysis.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Updating long COVID: mechanisms, risk factors, and treatment.Frontiers in human neuroscience · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The global concern regarding protection against the COVID-19 variants through pre-existing antibodies from vaccination or previous infection is evident. Reports from around the world indicate that a considerable number of healthcare professionals/individuals experience re-infection despite being vaccinated. Moreover, several studies have highlighted cases of symptomatic SARS-CoV-2 re-infection, specifically among individuals who have been vaccinated. Understanding the factors that contribute to these re-infections is crucial for implementing effective public health measures and enhancing vaccination strategies. Method: A comprehensive search was conducted between January 1, 2021, and February 14, 2024, using various reputable sources such as PubMed, Google scholar, Medline, EMBASE, CINAHL, and others. The search aimed to retrieve relevant research on topics related to "world nations" and phrases like "COVID-19 vaccination breakthrough infection," "SARS re-infection after COVID-19 vaccination," "COVID-19 vaccine complication," "post COVID-19 vaccination symptoms," and specific nation names. The data obtained from the databases underwent extraction and quality assessment using the Newcastle-Ottawa Scale (NOS) and the Preferred Reporting Items for Systematic Review and Meta-Analyses. Data analysis was performed using STATA Result: This review and meta-analysis comprised a total of 15 articles, or a total sample size of 342,598. The pooled prevalence of SARS-CoV-2 after vaccination of COVID-19 was 9 % (95CI 7%-11 %) of population globally. This implied that reduced the overall attack rate of COVID-19 by 91 % after vaccination. The highest pooled estimated of SARS-CoV-2 infection after COVID -19 Vaccinations was seen among developing nations, 20 % (95 % CI: 5%-36 %).The pooled odds ratio showed that a significant association was found between SARS-CoV-2 infection after COVID-19 vaccination and older age (OR = 2.04; 95%CI: 1.10-2.98) and comorbidity (OR = 3.25; 95%CI: 1.04-5.47). Conclusion: It is important for policymakers to prioritize continuous monitoring and surveillance of SARS-CoV-2 infection rates among vaccinated individuals globally, as there is a significant estimate of the combined prevalence of post-COVID-19 vaccine SARS-CoV-2 infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.